Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections

Go back to Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections
(NASDAQ: TYME) Delayed: 0.31 --0 (-0%)
Previous Close $0.31    52 Week High
Open $0.08    52 Week Low
Day High $0.31    P/E N/A 
Day Low $0.31    EPS
Volume 85,000